Dean's diagnosis: It is estimated that the net profit in 2025 will be between 28 million and 42 million yuan, turning losses into profits year-on-year.

Dean Diagnosis announcement, expected net profit for the year 2025 is 28-42 million yuan, a loss of 357 million yuan in the same period last year. In 2025, the company officially launched a new round of five-year strategic planning, upgrading its strategic positioning to become the leader in "medical diagnostic intelligent solutions". Adhering to "AI+ big data" as the technical engine, actively building a new ecosystem of health diagnosis and treatment digitalization integrating "research and development, production, diagnostic services, and health management". During the reporting period, the company focused on improving operational quality, focusing on high-value customers, strengthening special inspections and promoting proprietary products, deepening regional integrated operations, continuously consolidating the coverage advantages of existing markets, steadily increasing the number of new signed customers, and increasing net operating cash flow to about 1.8 billion yuan, the trend of operating efficiency is gradually improving; in terms of innovation and technology drive, the company accelerated the commercialization process of AI products, made breakthrough progress in data operations and transactions, obtaining registration certificates for three categories of medical devices, expanding overseas business, injecting strong new momentum for the high-quality development of the company.